Kilitch Drugs (India) Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Mira Mehta, was filed 27 Aug 2024.
Kilitch Drugs (India) Limited: what insiders have been doing
Kilitch Drugs (India) Limited belongs to the Health Care sector. Filings by its managers are published through SEBI (PIT + SAST). No insider at Kilitch Drugs (India) Limited has published a filing in the past twelve months. The most recent one dates from 27 August 2024.
Elsewhere in the same sector, our signals recently picked up insider purchases at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 841,046 sharesEquity SharesSEBI:ad7b53eb58fd2789c81050a2f543bf17130608f5Canonical exit: 21 Nov 2024 (T+90)
- 841,046 sharesEquity SharesSEBI:7a638dcf214437f630876cd203cd4f0599c81a20
- 1,111,768 sharesEquity SharesSEBI:ebdf33aa3fe450d0e17b0bc9392cdd08a9dcdfc8Canonical exit: 21 Jul 2022 (T+90)
- 1,111,768 sharesEquity SharesSEBI:6703b2175c031c21f53e908e7d8d64ee8034ff6e
- 1,111,768 sharesEquity SharesSEBI:59d5bb698dfa9c3261b555b8e7b715c8a91af1caCanonical exit: 10 Jul 2022 (T+90)
5 of 5 declarations
About Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited is a company engaged in the manufacturing of pharmaceutical products. It operates on the Bombay Stock Exchange.
